Vol. 22/No. 20 | OncologyLive

New Strategies Are Needed for Patients With NRAS-Mutant Melanoma

November 03, 2021

Although there has been dramatic progress in the treatment landscape for metastatic melanoma over the past decade, many patients whose tumors harbor NRAS mutations have not shared in the improved outcomes.

A Dynamic Treatment Landscape Emerges for Early-Stage TNBC

November 02, 2021

Partner Perspective

Standard chemotherapy has historically been the mainstay of treatment for patients with diagnoses of early-stage TNBC, but there remains an unmet need to identify novel therapies that improve outcomes and, equally important, to discern which patients may benefit from a given treatment.

A New Era of Precision Medicine Takes Shape in Prostate Cancer

October 26, 2021

OncologyLive

Prostate cancer is a highly hetero-geneous disease, with individual tumor cells having distinct genomic and pheno-typic characteristics, resulting in a great deal of variability in patients’ disease course.